Aildenafil citrate: a new potent and highly selective phosphodiesterase type 5 inhibitor for the treatment of erectile dysfunction

Zhonghua nan ke xue = National journal of andrology

Volumn 12, Issue 12, 2006, Pages 1080-1083

  He, Zhan ju ^a   Zhang, Kai ^a   Jin, Jie ^a   Li, Ning chen ^a   Na, Yan qun ^a   Bai, Wen jun ^a   Wang, Xiao feng ^a   Zhu, Ji chuan ^a   Jiang, Hui ^a   Yuan, Ren pei ^a   Hong, Bao fa ^a   Song, Tao ^a   Yang, Yong ^a   Dai, Dong xi ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AILDENAFIL; PHOSPHODIESTERASE INHIBITOR; PIPERAZINE DERIVATIVE; SULFONE; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; HUMAN; IMPOTENCE; MALE; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; HUMANS; IMPOTENCE; MALE; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; SULFONES; TREATMENT OUTCOME;

EID: 35448979620     PISSN: 10093591     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)